Adenosine A(2a) receptors in the nucleus accumbens modulate prepulse inhibition of the startle response

NeuroReport

Volumn 8, Issue 6, 1997, Pages 1515-1518

  Hauber, Wolfgang ^a   Koch, Michael ^b  

^a UNIVERSITY OF STUTTGART   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acoustic startle response; Adenosine A(2a) receptors; Apomorphine; CGS21680; Dopamine D2 receptors; Prepulse inhibition; Rat

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE DERIVATIVE; APOMORPHINE; NEUROLEPTIC AGENT; ADENOSINE; ADENOSINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; AUTORADIOGRAPHY; CONTROLLED STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; STARTLE REFLEX; ACOUSTIC REFLEX; ANALYSIS OF VARIANCE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; INFUSION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; DOPAMINE AGONISTS; INFUSIONS, PARENTERAL; MALE; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; REFLEX, ACOUSTIC; STARTLE REACTION;

EID: 0030612294     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199704140-00038     Document Type: Article

References (24)

1. Hoffman HS and Ison JR. Psychol Rev 2, 175-189 (1980).
2. Swerdlow NR, Braff DL, Taaid N and Geyer MA. Arch Gen Psychiatry 51, 139-154 (1994).
3. Swerdlow NR, Braff DL, Masten VL and Geyer MA. Psychopharmacology 101, 414-420 (1990).
4. Swerdlow NR, Braff DL, Geyer MA and Koob GF. Biol Psychiatry 21, 23-33 (1986).
5. Ferré S, O'Connor WT, Snaprud P et al. Neuroscience 63, 765-773 (1994).
6. Collis MG and Hourani SMO. Trends Pharmacol Sci 14, 360-366 (1993).
7. Jarvis MF and Williams M. Eur J Pharmacol 168, 243-246 (1989).
8. Fuxe K, Ferré S, Snaprud P et al. Drug Dev Res 28, 374-380 (1993).
9. Morelli M, Fenu S, Pinna A and Di Chiara G. Eur J Pharmacol 251, 21-25 (1994).
10. Ferré S, Herrera-Marschitz M, Grabowska-Andén M et al. Eur J Pharmacol 192, 25-30 (1991).
11. Pellegrino LJ, Pellegrino AS and Custman AJ. A Stereotaxic Atlas of the Rat Brain. New York: Plenum Press, 1981.
12. Mansbach RS, Geyer MA and Braff DL. Psychopharmacology 94, 507-514 (1988).
13. Hauber W and Münkle M. Eur J Pharmacol, in press.
14. Hauber W and Münkle M. Neurosci Lett 196, 205-208 (1995).
15. Ferré S, Rubio A and Fuxe K. Neurosci Lett 130, 162-164 (1991).
16. Peng RY, Mansback RS, Braff DL and Geyer MA. Neuropsychopharmacology 3, 211-218 (1988).
17. Wan F-J, Taaid N and Swerdlow NR. Neuropsychopharmacology 14, 265-274 (1996).
18. Vellucci SV, Sirinathsinghji DJS and Richardson PJ. Psychopharmacology 111, 383-388 (1993).
19. Svenningsson P, Nomikos GG and Fredholm BB. J Neurosci 15, 7612-7624 (1995).
20. Swerdlow NR and Geyer MA. Pharmacol Biochem Behav 44, 741-744 (1993).
21. Kafka SH and Corbett R. Eur J Pharmacol 295, 147-154 (1996).
22. Duran MJ and Morgan PF. Eur J Pharmacol 68, 285 (1989).
23. Heffner TG, Wiley JN, Williams RF et al. Psychopharmacology 98, 31-36 (1989).
24. Martin GE, Rossi DJ and Jarvis MF. Pharmacol Biochem Behav 45, 951-958 (1993).